By Titik Puspa 
Telluride, Colorado – In a move that sent ripples of anticipation and intrigue through the elite circles of the film festival, the Telluride Film Festival on Sunday night executed what The Hollywood Reporter has lauded as "one of its best-kept secrets in years." Festivalgoers, accustomed to curated previews and meticulously planned reveals, were ushered into a 650-seat theater with a specific, yet tantalizingly vague, directive: their mobile devices were to be surrendered, their curiosity piqued by the promise of a nearly three-hour cinematic experience that had never before graced the public eye. The only further information provided was the presence of the film’s principal creators in the audience, a detail that only amplified the air of mystery surrounding the undisclosed project. The surprise premiere, a hallmark of Telluride’s distinctive approach to launching cinematic contenders, turned out to be a groundbreaking documentary co-directed by the inimitable Nathan Fielder and the emerging talent Lance Oppenheim, offering an unflinching look at the enigmatic figure of Elizabeth Holmes, the disgraced founder of the revolutionary (and ultimately fraudulent) blood-testing company Theranos.
Titled "You Can See Everything," the documentary delves into an extraordinary period in Holmes’s life: the 34 days leading up to her May 2023 surrender to federal prison to commence an 11-year sentence for defrauding investors. The conviction stemmed from her elaborate deception regarding the capabilities of Theranos’s proprietary blood-testing technology, a narrative that captivated Silicon Valley and the wider world before its spectacular implosion. Holmes’s subsequent legal battles have been a protracted and ultimately unsuccessful endeavor to escape accountability. Her initial appeals to overturn her conviction and secure a reduced sentence were definitively rejected in February of the preceding year. Undeterred, Holmes then pivoted to a different strategy, reportedly petitioning then-President Trump for a commutation of her sentence. This clemency petition, as confirmed by official records, remains in a pending status, indicating that it has been formally opened and is still under review by the Department of Justice’s pardon attorney. The existence of this ongoing clemency process adds another layer of complexity and ongoing drama to Holmes’s post-conviction narrative, a narrative that "You Can See Everything" appears poised to illuminate.
The level of access granted to Fielder and Oppenheim for "You Can See Everything" is reportedly nothing short of astonishing. According to industry whispers and initial reports, Fielder himself resided in the couple’s guest house during the filming period, a testament to the unprecedented trust and openness extended by Holmes and her husband, Billy Evans. This deep immersion into their private lives has fueled considerable buzz, suggesting that the documentary will offer intimate, never-before-seen footage and insights into the mindset and daily existence of Holmes as she navigated the precipice of her incarceration. The film’s narrative is further enhanced by the reported involvement of an A-list actress who becomes an integral part of the story itself, although details regarding her role remain tightly guarded secrets, adding another layer of star power and potential critical acclaim to the project. A24, the acclaimed independent film studio known for its distinctive and artistically driven productions, has secured the distribution rights for "You Can See Everything," with a planned release slated for October, positioning it as a significant contender in the upcoming awards season. The release of the official teaser trailer has only intensified anticipation, offering a tantalizing glimpse into the film’s cinematic style and thematic scope.
The story of Elizabeth Holmes and Theranos has been a cautionary tale that has captivated legal scholars, business analysts, and the general public for years. Founded in 2003, Theranos promised to revolutionize healthcare with its Edison device, a proprietary machine that claimed to perform a wide range of diagnostic tests using only a few drops of blood from a finger prick. Holmes, a charismatic Stanford University dropout, became a darling of the tech world, attracting billions of dollars in investment and garnering comparisons to tech titans like Steve Jobs. Her meticulously crafted public image, complete with black turtlenecks and a deep, synthesized voice, projected an aura of genius and unwavering conviction. However, beneath the veneer of innovation and visionary leadership lay a foundation of deception and scientific fraud. Investigations by The Wall Street Journal, led by investigative journalist John Carreyrou, revealed that the Edison device was unreliable and that Theranos was secretly using conventional laboratory equipment to perform most of its tests, often with inaccurate results.
The fallout from these revelations was swift and devastating. Investors lost billions, patients were potentially exposed to inaccurate diagnoses, and the once-celebrated unicorn startup collapsed. Holmes was indicted on federal fraud charges in 2018, alongside Theranos’s former chief operating officer, Ramesh "Sunny" Balwani. The subsequent trial of Elizabeth Holmes was a media circus, meticulously documenting the rise and fall of a Silicon Valley prodigy. The prosecution presented a compelling case, highlighting Holmes’s deliberate lies and her awareness of the company’s technological shortcomings. Her defense team attempted to portray her as a visionary entrepreneur who was misled by her employees and the pressures of the demanding tech industry. Ultimately, the jury found her guilty on four counts of wire fraud and conspiracy to commit wire fraud, a verdict that sent shockwaves through the business world and served as a stark reminder of the ethical boundaries within the pursuit of innovation.
The documentary "You Can See Everything" enters this narrative landscape at a crucial juncture. The 34 days preceding Holmes’s prison sentence represent a period of profound transition, a time when the weight of her conviction and impending incarceration would have been most acutely felt. The unprecedented access granted to Fielder and Oppenheim suggests a desire on Holmes’s part to shape her own narrative, or perhaps to offer a final, unvarnished perspective before entering a period of enforced silence. The film’s title itself, "You Can See Everything," carries a profound irony, given the years of deliberate obfuscation and secrecy that characterized the Theranos saga. It hints at a revelation, a stripping away of the artifice that once surrounded Holmes and her company.
Nathan Fielder, known for his groundbreaking and often darkly humorous reality television series such as "Nathan for You" and "The Rehearsal," brings a unique sensibility to documentary filmmaking. His work consistently explores the absurdities of human behavior, the complexities of social interaction, and the blurred lines between performance and reality. His involvement in a project focused on Elizabeth Holmes suggests an interest in the psychological underpinnings of her deception and the performative aspects of her public persona. Lance Oppenheim, whose previous work includes the documentary "Some Kind of Heaven," which offered an intimate portrait of residents in a Florida retirement community, has demonstrated a talent for empathetic and insightful storytelling that delves into the lives of individuals navigating unique and often challenging circumstances. The collaboration between these two directors promises a film that is both intellectually stimulating and emotionally resonant, likely eschewing a conventional biographical approach for a more nuanced and perhaps even provocative exploration of its subject.
The decision by A24 to distribute "You Can See Everything" further amplifies its potential impact. A24 has a proven track record of championing films that push creative boundaries and resonate with discerning audiences, often leading to critical acclaim and awards recognition. Their involvement signals confidence in the documentary’s artistic merit and its capacity to generate significant cultural conversation. The film’s October release date strategically positions it within the critical window for awards consideration, setting the stage for potential nominations and wins at major ceremonies like the Academy Awards, the Golden Globes, and the BAFTA Awards.
The inclusion of an A-list actress as a part of the narrative, even if her specific role remains undisclosed, is a significant factor. This could indicate a variety of possibilities: she might be participating in interviews, acting as a narrator, or even portraying a figure connected to Holmes’s story. Regardless of her exact contribution, her presence is likely to draw additional attention to the documentary and potentially lend a layer of gravitas or emotional depth to the storytelling. The mystery surrounding her involvement only serves to heighten the anticipation surrounding the film’s release.
The broader context of documentaries about fraud and deception is also relevant here. Films like "Fyre," "The Inventor: Out for Blood in Silicon Valley," and "The Dropout" (a fictionalized series starring Amanda Seyfried) have all explored the allure and the devastating consequences of elaborate scams. "You Can See Everything" has the potential to offer a fresh perspective on the Elizabeth Holmes saga, moving beyond the sensationalism of her downfall to explore the human element of her experience, the motivations behind her actions, and the impact of her choices on those around her. The unprecedented access suggests a departure from previous portrayals, which have largely relied on archival footage, news reports, and interviews with those affected by her actions.
The legal aftermath for Elizabeth Holmes continues to evolve. While her conviction and prison sentence are set, the pending clemency petition introduces an element of ongoing uncertainty. The possibility, however remote, of a presidential intervention adds another layer to her story, raising questions about fairness, executive power, and the potential for rehabilitation. The documentary’s focus on the 34 days leading up to her surrender could capture this period of intense legal maneuvering and personal reflection, offering a glimpse into Holmes’s state of mind as she prepared to face the consequences of her actions.
In conclusion, the surprise premiere of "You Can See Everything" at the Telluride Film Festival marks a significant moment in documentary filmmaking. The collaboration between Nathan Fielder and Lance Oppenheim, coupled with unprecedented access to Elizabeth Holmes during a pivotal period in her life, promises a deeply compelling and potentially controversial exploration of one of the most talked-about figures in recent business history. With A24 at the helm and the involvement of an undisclosed A-list actress, the documentary is poised to be a major talking point in the cultural landscape and a strong contender for awards recognition. The film’s success will likely hinge on its ability to navigate the complexities of Holmes’s narrative, offering audiences a nuanced and insightful perspective on the human drama behind the Theranos scandal, and perhaps, as its title suggests, allowing us to "see everything" that led to this extraordinary downfall. The teaser trailer, available for viewing, offers a compelling initial glimpse into the film’s aesthetic and thematic ambitions, leaving audiences eager for the full reveal in October.
